Form: 8-K

Current report filing

February 6, 2008

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

February 5, 2008

Date of Report (Date of earliest event reported)

ResMed Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware    001-15317    98-0152841

(State or Other Jurisdiction of

Incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

14040 Danielson Street

Poway, California 92064-6857

(Address of Principal Executive Offices) (Zip Code)

 

 

(858) 746-2400

(Registrant’s telephone number, including area code)

 

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 1.01. Entry into a Material Definitive Agreement

On February 5, 2008, ResMed Inc., and our wholly-owned subsidiaries, ResMed Corp., ResMed EAP Holdings Inc. and ResMed Motor Technologies Inc., entered into a Second Amendment to the March 1, 2006 Second Amended and Restated Revolving Loan Agreement with Union Bank of California, N.A.

In the Second Amendment, we agreed to certain changes in the loan agreement to reflect the proposed sale of our Poway, California real property (previously disclosed in our December 14, 2007 report on Form 8-K), and to reflect potential capital expenditures relating to real property we own in Sydney, New South Wales, Australia.

A copy of the Second Amendment is attached as Exhibit 10.1 to this report, and the summary above is qualified by reference to the entire document. No material relationships exist between us and the Lender.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibits:

  

Description of Document

10.1    Second Amendment to Second Amended and Restated Revolving Loan Agreement dated January 28, 2008


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 6, 2008     RESMED INC.
      By:   /s/ David Pendarvis
      Name:   David Pendarvis
      Its:  

Secretary, Global General

Counsel and Senior Vice

President –Organizational

Development


EXHIBIT INDEX

 

Exhibits:

  

Description of Document

10.1    Second Amendment to Second Amended and Restated Revolving Loan Agreement dated January 28, 2008